Japan’s Leading Drug Manufacturers Grow Sales Revenue on Back of Mainstay Products May. 18, 2022 Filed Under: Pharma Tagged With: business performance, pharmaceuticalDrug manufacturers across Japan have now released their business results for fiscal 2021. Looking at companies using the April–March fiscal…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Large Japanese Chemical and Material Firms to Generate…Nissan Chemical’s Market Capitalization Tops 1 Trillion Yen,…Growth in Asia–Pacific Chemicals Market Expected to Slow for…Nissan Chemical Looks to Boost Profitability From New…Coronavirus Report – Part 81: Impact on Chinese EconomyMajor Film Manufacturers Across Asia See Good Business…